Estrogen Replacement Therapy
"Estrogen Replacement Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.
Descriptor ID |
D015914
|
MeSH Number(s) |
E02.319.452.150
|
Concept/Terms |
Estrogen Replacement Therapy- Estrogen Replacement Therapy
- Estrogen Replacement Therapies
- Replacement Therapies, Estrogen
- Therapies, Estrogen Replacement
- Therapy, Estrogen Replacement
- Replacement Therapy, Estrogen
Estrogen Replacement- Estrogen Replacement
- Estrogen Replacements
- Replacements, Estrogen
- Replacement, Estrogen
|
Below are MeSH descriptors whose meaning is more general than "Estrogen Replacement Therapy".
Below are MeSH descriptors whose meaning is more specific than "Estrogen Replacement Therapy".
This graph shows the total number of publications written about "Estrogen Replacement Therapy" by people in this website by year, and whether "Estrogen Replacement Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 1 | 0 | 1 |
2017 | 9 | 3 | 12 |
2018 | 3 | 2 | 5 |
2019 | 4 | 1 | 5 |
2020 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Estrogen Replacement Therapy" by people in Profiles.
-
Beliefs, knowledge and the impact of COVID19 on menopause therapies in Spanish women: COMEM-treatment study. BMC Womens Health. 2020 12 28; 20(1):277.
-
Sexual Dimorphism of Coronavirus 19 Morbidity and Lethality. Trends Endocrinol Metab. 2020 12; 31(12):918-927.
-
Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes. Endocrinology. 2020 09 01; 161(9).
-
Osteoporosis Management in the Era of COVID-19. J Bone Miner Res. 2020 06; 35(6):1009-1013.
-
Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia. Maturitas. 2020 Jul; 137:57-62.
-
Hormone therapy study restokes debate over breast cancer risk. CMAJ. 2019 09 30; 191(39):E1088-E1089.
-
Hormone replacement therapy: changes in prescribing practice. BMJ. 2019 02 11; 364:l633.
-
Bioidentical hormone therapy in menopause: relevance in dermatology. Dermatol Online J. 2019 Jan 15; 25(1).
-
[Towards an optimization of the modulation of the estrogen receptor during menopausal hormonal therapy]. Med Sci (Paris). 2018 Dec; 34(12):1056-1062.
-
Computerized hybrid decision-making system for hormone replacement therapy in menopausal women. Technol Health Care. 2019; 27(1):49-59.